RhumbLine Advisers’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-46,907
| Closed | -$258K | – | 3310 |
|
|
2022
Q1 | $258K | Sell |
46,907
-1,114
| -2% | -$6.13K | ﹤0.01% | 2684 |
|
|
2021
Q4 | $465K | Sell |
48,021
-10,662
| -18% | -$103K | ﹤0.01% | 2540 |
|
|
2021
Q3 | $1.05M | Buy |
58,683
+1,652
| +3% | +$29.5K | ﹤0.01% | 2211 |
|
|
2021
Q2 | $1.39M | Sell |
57,031
-9,810
| -15% | -$239K | ﹤0.01% | 2104 |
|
|
2021
Q1 | $1.77M | Buy |
66,841
+7,585
| +13% | +$201K | ﹤0.01% | 1969 |
|
|
2020
Q4 | $450K | Buy |
59,256
+8,273
| +16% | +$62.8K | ﹤0.01% | 2483 |
|
|
2020
Q3 | $255K | Sell |
50,983
-7,365
| -13% | -$36.8K | ﹤0.01% | 2588 |
|
|
2020
Q2 | $349K | Buy |
58,348
+12,893
| +28% | +$77.1K | ﹤0.01% | 2503 |
|
|
2020
Q1 | $202K | Buy |
45,455
+93
| +0.2% | +$413 | ﹤0.01% | 2581 |
|
|
2019
Q4 | $431K | Buy |
45,362
+304
| +0.7% | +$2.89K | ﹤0.01% | 2426 |
|
|
2019
Q3 | $354K | Sell |
45,058
-215
| -0.5% | -$1.69K | ﹤0.01% | 2490 |
|
|
2019
Q2 | $712K | Buy |
45,273
+3,208
| +8% | +$50.5K | ﹤0.01% | 2216 |
|
|
2019
Q1 | $761K | Buy |
42,065
+25,736
| +158% | +$466K | ﹤0.01% | 2150 |
|
|
2018
Q4 | $263K | Buy |
16,329
+7,711
| +89% | +$124K | ﹤0.01% | 2603 |
|
|
2018
Q3 | $207K | Buy |
+8,618
| New | +$207K | ﹤0.01% | 2714 |
|